• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Edward Smolyansky Responds to ISS Board Recommendation

    12/19/25 10:26:00 AM ET
    $LWAY
    Packaged Foods
    Consumer Staples
    Get the next $LWAY alert in real time by email

    Highlights ISS concerns around Lifeway's governance, board practices and composition

    CHICAGO, Dec. 19, 2025 /PRNewswire/ -- Edward Smolyansky, largest individual shareholder of Lifeway Foods, Inc. (NASDAQ:LWAY), today drew attention to critical governance concerns identified by Institutional Shareholder Services ("ISS") in its recent proxy analysis. Mr. Smolyansky's full letter to the shareholders can be accessed here.

    In its report, ISS questioned Lifeway's approach to shareholder and proxy advisor engagement, noting that governance-related discussions were not led by the CEO or any incumbent director, but instead by the Company's Chief of Staff—who is also the spouse of CEO Julie Smolyansky. Despite holding no officer or board position, he acted as the Company's primary representative in matters that typically require direct board-level accountability. ISS further highlighted the lack of transparency surrounding this role, the absence of a clear framework for managing potential conflicts, and the fact that no directors were present to address these concerns.

    ISS's proxy analysis noted:

    • Engagement with ISS was led by Lifeway's Chief of Staff (also the CEO's spouse) rather than board members. The Chief of Staff described himself as responsible for a broad range of duties but confirmed he had no formal employment agreement, despite significant pay increases over the last two years.
    • The board combined CEO and chair roles without strong rationale, later reversed only through a Cooperation Agreement. Additionally, a 2021 major acquisition was executed without formal board approval, raising the question of process lapses.
    • Ongoing concerns with executive compensation, low shareholder support for pay proposals and renewal of a poison pill without shareholder vote.

    "ISS is effectively asking the question shareholders are now forced to ask," said Smolyansky. "Why is an unelected, non-officer family member serving as Lifeway's primary voice on governance, board independence, and shareholder relations?"

    "These aren't just superficial governance issues," Smolyansky said. "They indicate that the company is being run through unofficial power structures, hidden authority, and undisclosed influences—the very problems that governance reforms are supposed to remove, not reinforce."

    Shareholders are urged to closely review ISS's findings and consider whether Lifeway's governance structure, as currently practiced, provides credible, independent oversight.

    Edward Smolyansky

    Key Shareholder, Shareholder Nominee for the Board of Directors

    For More Information visit my Linkedin profile www.linkedin.com/in/edward-smolyansky-a2293627a

    Important Information

    This communication is not a request for a proxy to vote on any matter. Any written solicitation of a proxy by Mr. Smolyansky will be made through the definitive proxy statement (the "Shareholder Proxy Statement"). Lifeway shareholders are urged to read the Shareholder Proxy Statement, including any amendments or supplements thereto, and any other soliciting materials, when they become available as they will contain important information. Shareholders may obtain, free of charge, copies of the Shareholder Proxy Statement at sec.gov.

    Participants in the Solicitation

    Mr. Smolyansky has notified the Company of his intent to nominate himself and George Sent for election as directors of Lifeway at the 2025 Annual Meeting. Each of them may be deemed to be a participant in any solicitation of proxies by Mr. Smolyansky. Lifeway shareholders can find information regarding Mr. Smolyansky and Mr. Sent, and their respective direct or indirect interests, by security holdings or otherwise, in the Shareholder Proxy Statement and in Mr. Smolyansky's other filings with the SEC, all of which information is incorporated herein by reference.

    Contact: Edward Smolyansky, [email protected] 

    Cision View original content:https://www.prnewswire.com/news-releases/edward-smolyansky-responds-to-iss-board-recommendation-302647013.html

    SOURCE Edward and Ludmila Smolyansky

    Get the next $LWAY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LWAY

    DatePrice TargetRatingAnalyst
    11/13/2025$35.00Buy
    The Benchmark Company
    9/24/2024Outperform → Market Perform
    Noble Capital Markets
    5/30/2024$20.00Market Perform → Outperform
    Noble Capital Markets
    4/5/2024$25.00Buy
    Lake Street
    3/27/2024Outperform → Market Perform
    Noble Capital Markets
    2/26/2024$14.00Market Perform → Outperform
    Noble Capital Markets
    11/27/2023Outperform → Market Perform
    Noble Capital Markets
    11/14/2023$13.00Market Perform → Outperform
    Noble Capital Markets
    More analyst ratings

    $LWAY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Smolyansky Ludmila

    4 - Lifeway Foods, Inc. (0000814586) (Issuer)

    3/19/26 6:26:42 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    SEC Form 4 filed by Smolyansky Edward

    4 - Lifeway Foods, Inc. (0000814586) (Issuer)

    3/19/26 6:26:22 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    SEC Form 4 filed by Smolyansky Edward

    4 - Lifeway Foods, Inc. (0000814586) (Issuer)

    3/18/26 8:11:00 AM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    $LWAY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lifeway Foods® Announces Strong Fourth Quarter and Record-Breaking Full Year 2025 Results Led by the Company's Flagship Kefir

    Company achieves full year 2025 net sales of $212.5 million; up 19% year-over-year on a comparable basisRecord-breaking year marks six years of uninterrupted, volume-led annual net sales growthAnnual gross margin expansion of 140 basis points and net income growth of 54% reflect the Company's disciplined operational executionMORTON GROVE, Ill., March 17, 2026 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic foods, today announced financial results for the fourth quarter and full year ended December 31, 2025.

    3/17/26 9:00:00 AM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Lifeway Foods® to Report Fourth Quarter and Full Year 2025 Results on March 17, 2026

    MORTON GROVE, Ill., March 9, 2026 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced it will report financial results for the fourth quarter and full year ended December 31, 2025 on March 17, 2026 before market hours. A pre-recorded conference call and webcast with Julie Smolyanksy, Lifeway's President and Chief Executive Officer, discussing these results with additional comments and details will be made available through the "Investor Relat

    3/9/26 6:40:00 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Lifeway Foods® Celebrates 40 Years of Kefir Leadership with New Cultured Dairy Innovations at Expo West 2026

    MORTON GROVE, Ill., Feb. 27, 2026 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic products, will showcase its latest cultured dairy innovations, Muscle Mates™ and Probiotic Kefir Butter™, at Natural Products Expo West 2026 as the brand celebrates its 40th anniversary. Taking place March 3–6 at the Anaheim Convention Center in Anaheim, CA, Lifeway's interactive booth will highlight the company's leadership in fermented foods and four decades of category expertise. Leading the new lineup is

    2/27/26 1:30:00 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    $LWAY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    The Benchmark Company initiated coverage on Lifeway Foods with a new price target

    The Benchmark Company initiated coverage of Lifeway Foods with a rating of Buy and set a new price target of $35.00

    11/13/25 9:14:26 AM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Lifeway Foods downgraded by Noble Capital Markets

    Noble Capital Markets downgraded Lifeway Foods from Outperform to Market Perform

    9/24/24 8:32:49 AM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Lifeway Foods upgraded by Noble Capital Markets with a new price target

    Noble Capital Markets upgraded Lifeway Foods from Market Perform to Outperform and set a new price target of $20.00

    5/30/24 9:15:56 AM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    $LWAY
    SEC Filings

    View All

    SEC Form 144 filed by Lifeway Foods Inc.

    144 - Lifeway Foods, Inc. (0000814586) (Subject)

    3/19/26 4:45:17 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Lifeway Foods Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Lifeway Foods, Inc. (0000814586) (Filer)

    3/17/26 9:15:09 AM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    SEC Form 10-K filed by Lifeway Foods Inc.

    10-K - Lifeway Foods, Inc. (0000814586) (Filer)

    3/17/26 9:00:27 AM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    $LWAY
    Leadership Updates

    Live Leadership Updates

    View All

    Lifeway Foods® Celebrates 40 Years of Kefir Leadership with New Cultured Dairy Innovations at Expo West 2026

    MORTON GROVE, Ill., Feb. 27, 2026 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic products, will showcase its latest cultured dairy innovations, Muscle Mates™ and Probiotic Kefir Butter™, at Natural Products Expo West 2026 as the brand celebrates its 40th anniversary. Taking place March 3–6 at the Anaheim Convention Center in Anaheim, CA, Lifeway's interactive booth will highlight the company's leadership in fermented foods and four decades of category expertise. Leading the new lineup is

    2/27/26 1:30:00 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Leading Kefir Brand Lifeway Foods' CEO Julie Smolyansky Launches Industry Conversation to Explore New Voluntary Dairy Certification Standard

    Calls on Industry Partners to Join in Building a New Model for Public Health, Farmers,and Consumers MORTON GROVE, Ill., June 17, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY), the leading U.S. supplier of kefir and fermented probiotic products, today announced that CEO Julie Smolyansky is launching an open industry-wide conversation to explore the creation of a new voluntary dairy certification standard. The proposal is designed to balance public health, consumer demand, and farmer viability — and to create a new model of trust and transparency in the dairy marketplace. The announcement is one of many initiatives coming from Lifeway Foods as part of their 40th anniversary plans and

    6/17/25 12:45:00 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    $LWAY
    Financials

    Live finance-specific insights

    View All

    Lifeway Foods® Announces Strong Fourth Quarter and Record-Breaking Full Year 2025 Results Led by the Company's Flagship Kefir

    Company achieves full year 2025 net sales of $212.5 million; up 19% year-over-year on a comparable basisRecord-breaking year marks six years of uninterrupted, volume-led annual net sales growthAnnual gross margin expansion of 140 basis points and net income growth of 54% reflect the Company's disciplined operational executionMORTON GROVE, Ill., March 17, 2026 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic foods, today announced financial results for the fourth quarter and full year ended December 31, 2025.

    3/17/26 9:00:00 AM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Lifeway Foods® to Report Fourth Quarter and Full Year 2025 Results on March 17, 2026

    MORTON GROVE, Ill., March 9, 2026 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced it will report financial results for the fourth quarter and full year ended December 31, 2025 on March 17, 2026 before market hours. A pre-recorded conference call and webcast with Julie Smolyanksy, Lifeway's President and Chief Executive Officer, discussing these results with additional comments and details will be made available through the "Investor Relat

    3/9/26 6:40:00 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Lifeway Foods Delivers Record Q3 2025 Net Sales and Strong Net Income Growth Continuing Kefir Category Dominance

    Achieves $57.1 million in net sales, a 29% volume-led net sales increase on a comparable basis, driven by the Company's flagship Lifeway Kefir Record-breaking quarter marks six years of uninterrupted quarterly net sales growth Significant gross margin expansion of 300 basis points and net income growth of 19% reflects the Company's disciplined operational execution MORTON GROVE, Ill., Nov. 12, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic foods, today announced record financial results for the third quarter ended September 30, 2025.

    11/12/25 9:00:00 AM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    $LWAY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Lifeway Foods Inc.

    SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)

    11/15/24 4:33:49 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Amendment: SEC Form SC 13D/A filed by Lifeway Foods Inc.

    SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)

    11/15/24 8:53:57 AM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Amendment: SEC Form SC 13D/A filed by Lifeway Foods Inc.

    SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)

    9/23/24 4:07:26 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples